Saturday , September 26 2020
Home / FT Alphaville / GMO: on the comeback trail

GMO: on the comeback trail

Gallons of ink has been spilled on the question of when value-investing -- the practice of buying treasure priced like trash -- will begin to outperform the market after a torrid decade of returns. To add to the literature is Grantham Mayo van Otterloo’s (GMO) Ben Inker, Head of Asset Allocation at the storied investment firm, who addressed the potential for a reversal in its third quarter letter, released Thursday.In short, the current market reminds him of 2000 -- when the Nasdaq bubble peaked, and EM debt was ebbing near its lowest points -- and that’s reason for some cautious optimism. Well, for its portfolios at least.From the quarterly letter:Ever since 2000, we have always assumed that neither the pain from the 1990s, nor the opportunity set that the pain created, would come our way

FT Alphaville considers the following as important:

This could be interesting, too:

Emilie Openchowski writes Weekend reading: Measuring and achieving a U.S. economy that works for all edition

Timothy Taylor writes How the US Start-Up Industry is Faltering

Miles Kimball writes Raffaella Sadun and Jeffrey Polzer on What Has Happened to the Workday as a Result of the Shift to Remote Work (and Kids being at Home)

Eric Crampton writes Afternoon roundup

Gallons of ink has been spilled on the question of when value-investing -- the practice of...

FT Alphaville
FT Alphaville is a free daily news and commentary service giving finance professionals the information they need, when they need it. In a world where market professionals are inundated with information there is a pressing need to edit and filter, and hopefully sow a few ideas along the way. That’s where the FT Alphaville team comes in.

Leave a Reply

Your email address will not be published. Required fields are marked *